The global DNA vaccine market is estimated to grow at a CAGR of 42.4% during the forecast period. The massive benefits that DNA vaccine technology offer such as lower cost of production, lesser time and safety are attracting companies to invest in DNA vaccine technology. Many companies have their DNA vaccines in clinical trials. Collaborations and funding are taking place to promote the development for DNA based vaccines. For instance, Australian Research Council has provided a grant of $63,000 to take on the research to deliver an inhalable DNA vaccine.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/dna-vaccines-market

In April 2018, Coalition for Epidemic Preparedness Innovations (CEPI) funded a total amount of $56 million to Inovio for developing DNA vaccines for Lassa fever and Middle east respiratory syndrome. In Jan 2018, Bill and Melinda Gates Foundation has granted $1.4 million to the Wistar Institute (Philadelphia) to develop a synthetic DNA-based vaccine for malaria. Wistar Institute will collaborate with the Inovia Pharmaceuticals, Inc. and Johns Hopkins Malaria Research Center for this research initiative. With this research funding from the Gates Foundation, the Wistar Institute along with its collaborating partners will plan to develop this vaccine against Plasmodium falciparum.

A Full Report of Global DNA Vaccine Market is Available at: https://www.omrglobal.com/industry-reports/dna-vaccines-market

One of the major factors driving the growth of the DNA vaccine market includes the number of pipeline products that are to enter the market in the future. Many companies are heavily investing in DNA vaccine technology. A large number of vaccines are in phase 1 and phase 2 clinical trials. These investments by biotechnology companies are driving the growth of the DNA vaccine industry.

Current Market Trends Covered in the Global DNA Vaccine Market Report

Animal vaccine is the largest market for DNA vaccine
Animal DNA vaccines to grow at a rapid rate due to increasing awareness
DNA vaccine pipeline products are expected to boost the market in the future
Technological advancements will drive a successful human DNA vaccine

Global DNA Vaccine Market Segmentation

By Type

Animal DNA Vaccine
Human DNA Vaccine

By Technology

Plasmid DNA Vaccine Technology
Plasmid DNA Delivery Technology

By Application

Oncology
Infectious Diseases
Others

Global DNA Vaccine Market Segment by Region

North America

US
Canada

Europe

Germany
UK
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

COMPANY PROFILES

ASTELLAS PHARMA
BHARAT BIOTECH
DENDREON CORPORATION
INDIAN IMMUNOLOGICALS LIMITED
GE HEALTHCARE LIFE SCIENCES
GLAXOSMITHKLINE INC.
GREEN CROSS CORPORATION
INNOVIO BIOMEDICAL CORPORATION
IMMUNOMIC THERAPEUTICS
MERCK & CO.
PFIZER PHARMACEUTICALS
PROTEIN SCIENCES CORPORATION

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/dna-vaccines-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404